Inhibition of CD40L with Frexalimab in Multiple SclerosisNEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Blood-based NfL - A biomarker for differential diagnosis of parkinsonian disorderNeurol 88:930-937,922, Hansson, O.,et al, 2017